Spotlight on women in pharma: Şeyda Atadan Memiş, Takeda

As part of our Women in Pharma series, where we talk to leading figures in the life sciences, we hear from Şeyda Atadan Memiş, recently appointed general manager for Takeda UK and

FDA panel backs AZ’s PT027 asthma rescue drug, but in adults...

AstraZeneca has moved a step closer to bringing a first-in-class drug to market in the US that can be used to reduce severe asthma attacks, after an FDA advisory committee voted in favour o

Report: Reinventing product and portfolio value for the biop...

Gain practical advice on determining and communicating product and portfolio value, including why, in fast-paced and evolving markets, you need to consider the evidence requirements of a growing ne

Practical advice for Early Scientific Advice (ESA) in HTA su...

ABPI's judicial review could be pointless - lawyer

Lawyer warns that NICE could reinstate cost measures after review

Ensuring access: how to help patients seeking experimental t...

The impact of the debate on the Right-to-Try laws in the US and what needs to be done to improve access to innovative drugs.